Vidya Navaratnam

3.3k citations

42 papers · 1.6k indexed · 1 hit paper · h-index 16

Co-authors: Richard Hubbard Tricia M. McKeever Gísli Jenkins Andrew Fogarty Jennifer K Quint A. Fogarty Liam Smeeth C. J. P. Smith
Topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers)Sarcoidosis and Beryllium Toxicity Research (8 papers)Cystic Fibrosis Research Advances (8 papers)
Cited by: Pulmonary and Respiratory Medicine Physiology Speech and Hearing
Journals: CHEST Journal European Respiratory Journal Thorax
Partner nations: United Kingdom Australia United States

In The Last Decade

Vidya Navaratnam

33 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study

2015 354 citations Jennifer K Quint, Elizabeth R. C. Millett et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Vidya Navaratnam

Since Specialization

Citations

This map shows the geographic impact of Vidya Navaratnam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vidya Navaratnam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vidya Navaratnam more than expected).

Fields of papers citing papers by Vidya Navaratnam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vidya Navaratnam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vidya Navaratnam. The network helps show where Vidya Navaratnam may publish in the future.

Co-authorship network of co-authors of Vidya Navaratnam

This figure shows the co-authorship network connecting the top 25 collaborators of Vidya Navaratnam. A scholar is included among the top collaborators of Vidya Navaratnam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vidya Navaratnam. Vidya Navaratnam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study 2025 ·European Respiratory Journal ·Nan Yang,Francesco Federico,Stephen M. Humphries,John A. Mackintosh,Christopher Grainge,Helen E. Jo,Nicole Goh,Paul N. Reynolds,Peter Hopkins,Vidya Navaratnam,Yuben Moodley,E. Haydn Walters,Samantha Ellis,Gregory J. Keir,Christopher Zappala,Tamera J. Corte,Ian Glaspole,Athol U. Wells,Guang Yang,Simon Walsh	0
2	Treatable traits in interstitial lung disease: a narrative review 2025 ·Therapeutic Advances in Respiratory Disease ·Megan Harrison,(unknown),Fiona Lake,Vidya Navaratnam,(unknown),Yuben Moodley,Tamera J. Corte	0
3	Long‐term exposure to low concentrations of air pollution and decline in lung function in people with idiopathic pulmonary fibrosis: Evidence from Australia 2023 ·Respirology ·Qiang Zheng,(unknown),Lucy Leigh,Barbara de Graaff,Fay H. Johnston,Tamera J. Corte,Luke D. Knibbs,Petr Otáhal,Vidya Navaratnam,Julie A. Campbell,Ian Glaspole,Yuben Moodley,Peter Hopkins,John A. Mackintosh,Hasnat Ahmad,E. Haydn Walters,Andrew Palmer	13
4	Deep Learning-Based Quantification of Traction Bronchiectasis Severity For Predicting Outcome in Idiopathic Pulmonary Fibrosis 2023 ·(unknown),Nan Yang,Guang‐Zhong Yang,John A. Mackintosh,Lucio Calandriello,Nicole Goh,Peter Hopkins,Yuben Moodley,Paul N. Reynolds,Tamera J. Corte,Vidya Navaratnam,Simon Walsh	0
5	Association between perinatal and early life exposures and lung function in Australian Indigenous young adults: The Aboriginal Birth Cohort study 2023 ·Respirology ·Vidya Navaratnam,Douglas L. Forrester,Anne B. Chang,Shyamali C. Dharmage,Gurmeet Singh	2
6	The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument 2022 ·Quality of Life Research ·Qiang Zheng,(unknown),Barbara de Graaff,Julie A. Campbell,Tamera J. Corte,Ian Glaspole,Vidya Navaratnam,Peter Hopkins,Christopher Zappala,Hasnat Ahmad,Ting Zhao,Sacha Macansh,E. Haydn Walters,Andrew Palmer	3
7	Timing of onset of symptoms in people with idiopathic pulmonary fibrosis 2017 ·Thorax ·(unknown),Tricia M. McKeever,Jack Gibson,Vidya Navaratnam,Richard Hubbard,John Hutchinson	49
8	Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis 2017 ·American Journal of Respiratory Cell and Molecular Biology ·(unknown),(unknown),Debbie Clements,S. Miller,Anthony Habgood,Alison E. John,Vidya Navaratnam,Richard Hubbard,Gísli Jenkins,Simon R. Johnson	116
9	Cardiovascular Outcomes after a Respiratory Tract Infection among Adults with Non–Cystic Fibrosis Bronchiectasis: A General Population–based Study 2017 ·Annals of the American Thoracic Society ·Vidya Navaratnam,Adrian Root,Ian Douglas,Liam Smeeth,Richard Hubbard,Jennifer K Quint	18
10	Bronchiectasis and the risk of cardiovascular disease: a population-based study 2016 ·Thorax ·Vidya Navaratnam,Elizabeth R. C. Millett,John R. Hurst,Sara L. Thomas,Liam Smeeth,Richard Hubbard,Jeremy Brown,Jennifer K Quint	62
11	Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008 2016 ·European Respiratory Journal ·John Hutchinson,Tricia M. McKeever,Andrew Fogarty,Vidya Navaratnam,Richard Hubbard	96
12	Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008 2016 ·John Hutchinson,Tricia M. McKeever,Andrew Fogarty,Vidya Navaratnam,Richard Hubbard	5
13	Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort studybreakdown → 2015 ·European Respiratory Journal ·Jennifer K Quint,Elizabeth R. C. Millett,Miland Joshi,Vidya Navaratnam,Sara L. Thomas,John R. Hurst,Liam Smeeth,Jeremy Brown	354
14	Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century 2014 ·Annals of the American Thoracic Society ·John Hutchinson,Tricia M. McKeever,Andrew Fogarty,Vidya Navaratnam,Richard Hubbard	148
15	Risk Factors for Cardiovascular Disease in People With Idiopathic Pulmonary Fibrosis 2014 ·CHEST Journal ·(unknown),Helen Powell,Richard Hubbard,Vidya Navaratnam	48
16	Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance 2014 ·Orphanet Journal of Rare Diseases ·(unknown),Vidya Navaratnam,Rupesh I. Bhatt,Ian McCafferty,Richard Hubbard,Simon R. Johnson	19
17	The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis 2013 ·CHEST Journal ·Vidya Navaratnam,Andrew Fogarty,(unknown),Tricia M. McKeever,Richard Hubbard	52
18	S100 Natural History of Renal Angiomyolipoma in Sporadic and Tuberous Sclerosis Complex Associated Lymphangioleiomyomatosis: Implications For Clinical Care 2012 ·Thorax ·(unknown),Vidya Navaratnam,RB Hubbard,(unknown)	0
19	Does the presence of connective tissue disease modify survival in patients with pulmonary fibrosis? 2011 ·Respiratory Medicine ·Vidya Navaratnam,Noman Ali,C. J. P. Smith,Tricia M. McKeever,A. Fogarty,Richard Hubbard	41
20	Mortality trends in Asbestosis, Extrinsic Allergic Alveolitis and Sarcoidosis in England and Wales 2011 ·Respiratory Medicine ·Anthony J. Hanley,RB Hubbard,Vidya Navaratnam	21

About Vidya Navaratnam

Vidya Navaratnam is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology, having authored 42 papers that have together received 1.6k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (24 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Cystic Fibrosis Research Advances (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Physiology (422 citations) and Speech and Hearing (91 citations). Vidya Navaratnam has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Richard Hubbard, Tricia M. McKeever, Gísli Jenkins, Andrew Fogarty, Jennifer K Quint, A. Fogarty, Liam Smeeth, C. J. P. Smith, John Hutchinson and Elizabeth R. C. Millett. Their work appears in journals such as CHEST Journal, European Respiratory Journal and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact